Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders.

Madden LM, Hayashi RJ, Chan KW, Pulsipher MA, Douglas D, Hale GA, Chaudhury S, Haut P, Kasow KA, Gilman A, Murray LM, Shenoy S.

Biol Blood Marrow Transplant. 2016 May 6. pii: S1083-8791(16)30064-7. doi: 10.1016/j.bbmt.2016.04.025. [Epub ahead of print]

PMID:
27164064
2.

Metformin use and survival from lung cancer: A population-based cohort study.

Menamin ÚC, Cardwell CR, Hughes CM, Murray LM.

Lung Cancer. 2016 Apr;94:35-9. doi: 10.1016/j.lungcan.2016.01.012. Epub 2016 Jan 23.

PMID:
26973204
3.

The use of substrate materials and topography to modify growth patterns and rates of differentiation of muscle cells.

Murray LM, Nock V, Evans JJ, Alkaisi MM.

J Biomed Mater Res A. 2016 Jul;104(7):1638-45. doi: 10.1002/jbm.a.35696. Epub 2016 Mar 11.

PMID:
26916910
4.

Welfare Conditions of Donkeys in Europe: Initial Outcomes from On-Farm Assessment.

Dai F, Dalla Costa E, Murray LM, Canali E, Minero M.

Animals (Basel). 2016 Jan 8;6(1). pii: E5. doi: 10.3390/ani6010005.

5.

Low-dose aspirin and survival from lung cancer: a population-based cohort study.

Mc Menamin ÚC, Cardwell CR, Hughes CM, Murray LM.

BMC Cancer. 2015 Nov 17;15:911. doi: 10.1186/s12885-015-1910-9.

6.

Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.

Murray LM, Beauvais A, Gibeault S, Courtney NL, Kothary R.

Acta Neuropathol Commun. 2015 Sep 15;3:55. doi: 10.1186/s40478-015-0231-1.

7.

How far away is spinal muscular atrophy gene therapy?

Gillingwater TH, Murray LM.

Expert Rev Neurother. 2015;15(9):965-8. doi: 10.1586/14737175.2015.1070672. Epub 2015 Jul 18.

PMID:
26189552
8.

Comparison of equations for the calculation of LDL-cholesterol in hospitalized patients.

Martins J, Olorunju SA, Murray LM, Pillay TS.

Clin Chim Acta. 2015 Apr 15;444:137-42. doi: 10.1016/j.cca.2015.01.037. Epub 2015 Feb 7.

PMID:
25666083
9.

Bioimprinted polymer platforms for cell culture using soft lithography.

Murray LM, Nock V, Evans JJ, Alkaisi MM.

J Nanobiotechnology. 2014 Dec 30;12:60. doi: 10.1186/s12951-014-0060-6.

10.

Intensity dependent effects of transcranial direct current stimulation on corticospinal excitability in chronic spinal cord injury.

Murray LM, Edwards DJ, Ruffini G, Labar D, Stampas A, Pascual-Leone A, Cortes M.

Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S114-21. doi: 10.1016/j.apmr.2014.11.004. Epub 2014 Nov 22.

11.

A reduction in the human adenovirus virion size through use of a shortened fibre protein does not enhance muscle transduction following systemic or localised delivery in mice.

McFall ER, Murray LM, Lunde JA, Jasmin BJ, Kothary R, Parks RJ.

Virology. 2014 Nov;468-470:444-53. doi: 10.1016/j.virol.2014.08.026. Epub 2014 Sep 20.

12.

The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.

Liu H, Yazdani A, Murray LM, Beauvais A, Kothary R.

PLoS One. 2014 Jul 1;9(7):e101225. doi: 10.1371/journal.pone.0101225. eCollection 2014.

13.

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy.

Boyer JG, Deguise MO, Murray LM, Yazdani A, De Repentigny Y, Boudreau-Larivière C, Kothary R.

Hum Mol Genet. 2014 Aug 15;23(16):4249-59. doi: 10.1093/hmg/ddu142. Epub 2014 Apr 1.

14.

Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology.

Bowerman M, Michalski JP, Beauvais A, Murray LM, DeRepentigny Y, Kothary R.

Hum Mol Genet. 2014 Jul 1;23(13):3432-44. doi: 10.1093/hmg/ddu052. Epub 2014 Feb 4.

15.

Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy.

Boyer JG, Murray LM, Scott K, De Repentigny Y, Renaud JM, Kothary R.

Skelet Muscle. 2013 Oct 11;3(1):24. doi: 10.1186/2044-5040-3-24.

16.

A novel function for the survival motoneuron protein as a translational regulator.

Sanchez G, Dury AY, Murray LM, Biondi O, Tadesse H, El Fatimy R, Kothary R, Charbonnier F, Khandjian EW, Côté J.

Hum Mol Genet. 2013 Feb 15;22(4):668-84. doi: 10.1093/hmg/dds474. Epub 2012 Nov 6.

17.

Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.

Murray LM, Beauvais A, Bhanot K, Kothary R.

Neurobiol Dis. 2013 Jan;49:57-67. doi: 10.1016/j.nbd.2012.08.019. Epub 2012 Aug 30.

PMID:
22960106
18.

Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.

Bowerman M, Murray LM, Boyer JG, Anderson CL, Kothary R.

BMC Med. 2012 Mar 7;10:24. doi: 10.1186/1741-7015-10-24.

19.

A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.

Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R.

Neuromuscul Disord. 2012 Mar;22(3):263-76. doi: 10.1016/j.nmd.2011.09.007. Epub 2011 Nov 8.

PMID:
22071333
20.

Interventional repetitive I-wave transcranial magnetic stimulation (TMS): the dimension of stimulation duration.

Murray LM, Nosaka K, Thickbroom GW.

Brain Stimul. 2011 Oct;4(4):261-5. doi: 10.1016/j.brs.2010.12.003. Epub 2011 Jan 12.

PMID:
22032741
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk